Disclosure Of Interests In Other Entities [Text Block]

Sopharma AD - Filing #6218824

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
2,207,000 BGN
4,525,000 BGN
Non-controlling interests
11,893,000 BGN
13,326,000 BGN
Current assets
571,232,000 BGN
612,177,000 BGN
Non-current assets
633,746,000 BGN
629,935,000 BGN
Current liabilities
423,892,000 BGN
544,451,000 BGN
Non-current liabilities
122,218,000 BGN
131,066,000 BGN
Revenue
1,603,310,000 BGN
1,438,826,000 BGN
Profit (loss)
2,207,000 BGN
- BGN
- BGN
- BGN
89,496,000 BGN
- BGN
- BGN
- BGN
- BGN
91,703,000 BGN
89,496,000 BGN
25,280,000 BGN
- BGN
29,805,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
4,525,000 BGN
29,805,000 BGN
Comprehensive income
1,728,000 BGN
- BGN
- BGN
9,485,000 BGN
101,970,000 BGN
3,367,000 BGN
355,000 BGN
- BGN
- BGN
103,698,000 BGN
89,473,000 BGN
16,773,000 BGN
- BGN
29,614,000 BGN
637,000 BGN
- BGN
- BGN
37,000 BGN
- BGN
6,763,000 BGN
5,404,000 BGN
22,177,000 BGN
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
479,000 BGN
- BGN
- BGN
9,485,000 BGN
12,474,000 BGN
3,367,000 BGN
355,000 BGN
- BGN
- BGN
11,995,000 BGN
23,000 BGN
8,507,000 BGN
- BGN
191,000 BGN
637,000 BGN
- BGN
- BGN
37,000 BGN
- BGN
6,763,000 BGN
879,000 BGN
7,628,000 BGN
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
37,722,000 BGN
25,293,000 BGN
Depreciation and amortisation expense
53,187,000 BGN
46,633,000 BGN
Tax expense (income)
5,871,000 BGN
6,162,000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.